Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Why was lubiprostone discontinued?Condylox gel generic?Lubiprostone 24mcg soft gelatin capsules?Trikafta patent expiration date vertex pharmaceuticals?Tucatinib price per month europe?
See the DrugPatentWatch profile for leflunomide
Leflunomide is a prescription medicine used to treat certain inflammatory autoimmune diseases, most commonly rheumatoid arthritis. It helps reduce joint inflammation and damage by slowing the immune system’s harmful activity.
Leflunomide works by reducing the activity of immune cells involved in the inflammatory process. By interfering with pathways needed for immune-cell growth and activation, it lowers inflammation and disease activity over time.
It is primarily used for rheumatoid arthritis. In some cases, clinicians may prescribe it for other immune-mediated joint conditions depending on local practice and patient-specific factors.
Leflunomide is not a pain reliever. Symptoms often improve gradually over weeks as the medicine controls the underlying inflammation.
Because it affects immune function and can impact organs such as the liver, clinicians typically monitor blood tests during treatment.
For additional drug and patent-related background, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/
Other Questions About Leflunomide :